KUPANDO Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $26.9M

  • Investors
  • 8

KUPANDO General Information

Description

Developer of a biotechnology platform designed to stimulate innate immunity to address unmet needs in cancer and infectious diseases. The company offers dual TLR agonist therapies with innate immune-training capabilities, enabling patients with oncology and infectious disease conditions to have improved access to novel immune-activating treatments.

Contact Information

Website
www.kupando.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Willy-Brandt-Platz 2
  • 12529 Schönefeld
  • Germany
+49 030
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Willy-Brandt-Platz 2
  • 12529 Schönefeld
  • Germany
+49 030

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

KUPANDO Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series A) 18-Mar-2026 $26.9M Completed Pre-Clinical Trials
1. University Spin-Out 13-Mar-2018 Completed Startup
To view KUPANDO’s complete valuation and funding history, request access »

KUPANDO Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a biotechnology platform designed to stimulate innate immunity to address unmet needs in cancer and infecti
Drug Discovery
Schönefeld, Germany
8 As of 2025

Princeton, NJ
 

Foster City, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

KUPANDO Competitors (8)

One of KUPANDO’s 8 competitors is Bristol-Myers Squibb, a Corporation company based in Princeton, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bristol-Myers Squibb Corporation Princeton, NJ
Gilead Formerly VC-backed Foster City, CA
Amunix Pharmaceuticals Formerly PE-Backed South San Francisco, CA
Merck & Co. Corporation Rahway, NJ
Pfizer Pakistan Corporation Karachi, Pakistan
You’re viewing 5 of 8 competitors. Get the full list »

KUPANDO Patents

KUPANDO Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026139137-A1 Crystalline forms of a tlr4 agonist and methods for preparing the same Pending 27-Dec-2024
WO-2026139641-A1 Crystalline forms of a tlr4 agonist and methods for preparing the same Pending 27-Dec-2024
WO-2026139138-A1 Pharmaceutical composition comprising tlr4 and tlr7 agonists Pending 27-Dec-2024
WO-2026139642-A1 Pharmaceutical composition comprising tlr4 and tlr7 agonists Pending 27-Dec-2024
WO-2026139139-A1 Pharmaceutical composition for medical use comprising tlr4 and tlr7 agonists Pending 27-Dec-2024 A61K9/1075
To view KUPANDO’s complete patent history, request access »

KUPANDO Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

KUPANDO Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Brandenburg Kapital Venture Capital Minority
CARMA FUND Management Venture Capital Minority
European Commission Government Minority
High-Tech Gründerfonds Venture Capital Minority
LifeCare Partners Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

KUPANDO FAQs

  • When was KUPANDO founded?

    KUPANDO was founded in 2018.

  • Where is KUPANDO headquartered?

    KUPANDO is headquartered in Schönefeld, Germany.

  • What is the size of KUPANDO?

    KUPANDO has 8 total employees.

  • What industry is KUPANDO in?

    KUPANDO’s primary industry is Drug Discovery.

  • Is KUPANDO a private or public company?

    KUPANDO is a Private company.

  • What is KUPANDO’s current revenue?

    The current revenue for KUPANDO is .

  • How much funding has KUPANDO raised over time?

    KUPANDO has raised $26.9M.

  • Who are KUPANDO’s investors?

    Brandenburg Kapital, CARMA FUND Management, European Commission, High-Tech Gründerfonds, and LifeCare Partners are 5 of 8 investors who have invested in KUPANDO.

  • Who are KUPANDO’s competitors?

    Bristol-Myers Squibb, Gilead, Amunix Pharmaceuticals, Merck & Co., and Pfizer Pakistan are some of the 8 competitors of KUPANDO.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process